Bauman et al. showed an association of neovascularization (assessed based on the average CD105/CD31 expression ratio) with decreased overall survival (HR, 1.54 [95% CI, 1.06–2.23]) in 251 RCC patient tissues [108]. This evidence concerns the gene PECAM1 and renal cell carcinoma.